
Glacial Acetic Acid (99,8%) - China CAS: 64-19-7

India's medical device polymer procurement — PP for syringe barrels, PVC for IV bags and tubing, PC for connectors

This week's specialty chemical intelligence highlights five procurement priorities, from supply chain resilience and helium planning to LABSA sourcing, biosurfactants, and regulatory readiness.

The VCI Q2 2026 half‑year data paints a challenging picture for European specialty coatings manufacturers. Rising feedstock prices, soaring energy costs, and plant closures are tightening margins and forcing structural rationalization. Procurement teams now rely on this report as a key supplier health indicator, blending financial resilience with technical performance.

China’s urea export limits and aggressive methanol-to-olefins (MTO) rates set the stage for 2026 chemical flows. July pricing decisions will reveal whether China will defend its crisis‑era share or recalibrate toward market balance. Global buyers must watch China’s export strategy closely.

Pharmaceutical packaging costs are beginning to ease as Gulf polymer supply recovers and crude prices fall, but India’s June 30 duty waiver decision could quickly reverse cost relief for manufacturers dependent on Indian packaging components.

By 2026 the global ascorbic acid market will still be anchored by China, yet freight cost inflation and new regulatory pressures are reshaping procurement strategies. Companies must navigate logistics premiums, ensure ICs2 compliance, and diversify suppliers to mitigate risk.
We're committed to your privacy. Tradeasia uses the information you provide to us to contact you about our relevant content, products, and services. For more information, check out our privacy policy.